Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | bluebird bio Bolsters Management Team with Appointments | ||
Di | Frontage Expands Business in Canada with New Leadership | ||
Di | BioMarin Completes Acquisition of Inozyme Pharma for $270M | ||
Di | Merck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M | ||
Di | Fresenius Expands Biosimilars Portfolio with Denosumab Biosimilars in the U.S. | ||
Mo | AAPS Reveals Opening & Closing Plenary Speakers for 2025 PharmSci 360 | ||
Mo | Particle Dynamics Acquires EUROAPI UK | ||
Mo | UI Pharmaceuticals Partners with MimiVax for Glioblastoma Vaccine | ||
Mo | Keystone Folding Box Co., Med-Con Technologies Partner to Enhance Key-Pak | ||
Mo | Piramal Pharma Solutions Breaks Ground on New Expansion | ||
Mo | Veranova Appoints Dr. Matteo Villain as VP of Peptides & Oligonucleotides | ||
Mo | ProFound Therapeutics Inks $70M+ Deal with Novartis | ||
Mo | FDA Approves Takeda's Gammagard Liquid ERC | ||
Mo | Mabion, NovalGen Partner to Bring NVG-222 to Market | ||
Mo | Circio, NeoRegen Biotech to Advance Circular RNA Delivery Collaboration | ||
Mo | Hikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities | ||
Fr | Vetter Breaks Ground on Des Plaines Manufacturing Site | ||
Fr | FDA Approves REMS Programs in BMS Cell Therapy Labels | ||
Fr | PrioBio Opens Flagship Cell & Gene Therapy Center of Excellence in Hopewell, NJ | ||
Do | GenSight Transfers Upstream Phase of LUMEVOQ Manufacturing Process to Catalent | ||
Do | Incyte Appoints Bill Meury Chief Executive Officer | ||
Do | AGC Biologics Expands Cell Therapy Development Operations to Asia | ||
25.06. | MAIA Biotechnology, Roche Partner for Hard-to-Treat Cancer Therapies | ||
25.06. | Silo Pharma, Hoth Therapeutics Enter LOI to Develop Obesity Treatment | ||
25.06. | Bio-Thera & SteinCares Ink Dupilumab Biosimilar Deal for Latin America |